{"nctId":"NCT05147233","briefTitle":"A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","startDateStruct":{"date":"2022-06-24","type":"ACTUAL"},"conditions":["Inflammation Eye Pain","Postoperative Cataract"],"count":241,"armGroups":[{"label":"OCS-01","type":"EXPERIMENTAL","interventionNames":["Drug: OCS-01"]},{"label":"Vehicle","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Vehicle"]}],"interventions":[{"name":"OCS-01","otherNames":[]},{"name":"Vehicle","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Be planning to undergo unilateral cataract extraction via phacoemulsification and posterior chamber intraocular lens (PCIOL) implantation in the study eye.\n* Have a pin-hole visual acuity (VA) without any other correction \\> 20 letters (approximately 20/400) in the operative eye and \\> 35 letters (approximately 20/200) in the fellow eye as measured using an Early Treatment for Diabetic Retinopathy Study (ETDRS) chart at Visit 1 (Day -1 to Day -28 \\[prior to surgery\\]).\n\nExclusion Criteria:\n\n* Have any intraocular inflammation (e.g. white blood cells or flare) present in either eye at the Visit 1 (Day -1 to Day -28 \\[prior to surgery\\]) slit lamp examination.\n* Have a score \\> 0 on the Ocular Pain Assessment at Visit 1 (Day -1 to Day -28 \\[prior to surgery\\]) in the study eye.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absence of Anterior Chamber Cells at Visit 6.","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57.2","spread":null},{"groupId":"OG001","value":"24.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Absence of Ocular Pain at Visit 4.","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75.5","spread":null},{"groupId":"OG001","value":"52.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":119},"commonTop":["Eye Pain"]}}}